We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 90

Full Court warns against dangerous affliction of parameteritis (and confirms invalidity of aripiprazole patent)
  • King & Wood Mallesons
  • Australia
  • August 26 2016

On Wednesday the Full Court of the Federal Court of Australia handed down a decision in which it upheld Justice Yates' findings that Otsuka's patent


Off to a running start? Federal Court of Australia permits generic manufacturer to make PBS application before patent expiry
  • King & Wood Mallesons
  • Australia
  • April 28 2017

Can a manufacturer apply for Pharmaceutical Benefits Scheme (PBS) approval for a generic drug before the patent has expired? Justice Nicholas held in


Generic Health succeeds in invalidating patent for aripiprazole: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) 2015 FCA 634
  • King & Wood Mallesons
  • Australia
  • July 7 2015

Generic Health is perhaps a step closer to bringing its generic version of the antipsychotic drug aripiprazole to market in Australia after Justice


Privacy Commissioner’s decision set aside by the Federal Court
  • King & Wood Mallesons
  • Australia
  • March 16 2015

A recent decision by Federal Court of Australia illustrated two things about privacy complaints - or at least those that end up before the courts:


Australian case notes - Odisho v Bonazzi 2014 VSCA 11
  • King & Wood Mallesons
  • Australia
  • May 20 2014

In this case the appellant, a patient who suffered a thromboembolic event following the use of tranexamic acid, claimed that her doctor had


High Court states the obvious: AstraZeneca AB v Apotex Pty Ltd appeal decided
  • King & Wood Mallesons
  • Australia
  • September 3 2015

In a widely anticipated decision, the High Court has upheld a decision of the Full Federal Court (which was made by five, rather than the usual three


Food law: quick bites and upcoming calendar
  • King & Wood Mallesons
  • Australia
  • April 30 2015

The ACCC is seeking leave to appeal the Federal Court decision dismissing its case against Pfizer for alleged misuse of market power and exclusive


Experimental evidence comply with the rules or risk inadmissibility
  • King & Wood Mallesons
  • Australia
  • March 22 2013

By refusing to allow Generic Health to adduce experimental evidence in a patent case currently being heard in the Federal Court, Justice Jagot has


Pharmaceuticals - copyright in PIs and indirect patent infringement
  • King & Wood Mallesons
  • Australia
  • August 4 2011

In the recent decision in Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3), Justice Jagot of the Federal Court found liability for indirect patent infringement in the context of supply of a pharmaceutical product


High Court finds patent for isolated breast cancer gene invalid and re-invents test for patentable subject matter
  • King & Wood Mallesons
  • Australia
  • October 8 2015

The High Court has handed down a significant decision finding that patent claims for isolated gene sequences, indicative of a predisposition to